Medical Litigation News and Research

RSS

Patent office ruling in favor of Neuralstem leads to stay of Stemcells Inc. lawsuit

Neuralstem Inc. has announced that StemCells Inc. has consented to a stay of the lawsuit it filed against Neuralstem in August 2006.

27 Jun 2007

Pain management is a fundamental human right

A growing international consensus urges change in several areas - including increased availability of controlled medications such as opioids - toward the goal of recognizing effective treatment for pain as a fundamental human right, according to a special article in the July issue of Anesthesia & Analgesia, the official publication of the International Anesthesia Research Society and published by Lippincott Williams & Wilkins.

27 Jun 2007

Ranbaxy receives tentative FDA approval for Tamsulosin capsules

Ranbaxy Pharmaceuticals has announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Tamsulosin Hydrochloride Capsules, 0.4 mg.

23 Jun 2007

Thermage sues Alma Lasers for patent infringement

Thermage, Inc. has announced that it has filed a patent infringement lawsuit against Alma Lasers, Ltd. and Alma Lasers, Inc. in Delaware Federal District Court.

23 Jun 2007

U.S. DOJ investigation of Bristol-Myers Squibb in Plavix patent settlement resolved

Bristol-Myers Squibb has pleaded guilty to two counts of violating 18 U.S.C. Sec. 1001 in U.S. District Court for the District of Columbia. This guilty plea resolved as to the company the previously disclosed investigation by the Antitrust Division of the U.S. Department of Justice into the proposed settlement of the Plavix patent litigation with Apotex Inc., and Apotex Corp. (Apotex).

16 Jun 2007

BioGenex settles patent case with Ventana

BioGenex Laboratories announced a settlement of patent litigation with Ventana Medical Systems (VMSI), ending the dispute between the two companies.

3 Jun 2007

Damages caps in medical malpractice cases

Caps on medical malpractice damages mean lower insurance premiums for doctors, according to a new review from two Alabama universities.

1 Jun 2007

Mylan wins Omeprazole patent litigation

Mylan Laboratories Inc. has announced that the United States District Court for the Southern District of New York has ruled that Mylan's 10 mg and 20 mg omeprazole delayed-release capsules, which are the generic versions of AstraZeneca LP's Prilosec, do not infringe patents asserted against it by AstraZeneca.

1 Jun 2007

When it comes to disclosing medical errors to patients, there is a gap between physicians' attitudes and their real-world experiences

From a survey of faculty physicians, resident physicians and medical students, researchers found that while nearly all respondents indicated that they would disclose a hypothetical error, less than half reported having disclosed an actual minor or major medical error.

11 May 2007

Spherix starts phase 3 clinical trial of treatment for type 2 diabetes

Spherix Incorporated has announced that it has begun its Phase 3 clinical trial of Naturlose as a treatment for Type 2 diabetes.

2 May 2007

Outdated policies are impediment for Americans with disabilities

Although the Americans with Disabilities Act (ADA) has helped increase awareness of barriers faced by people with disabilities, and advances in science and engineering have led to better assistive technologies that make it easier for individuals to lead productive, independent lives, outdated regulations too often impede access to health care coverage and assistive devices for many who need them, says a new report by the Institute of Medicine.

27 Apr 2007

DuPont settles patent case with Bio-Rad Laboratories

DuPont has announced that it has settled patent infringement litigation against Bio-Rad Industries, Inc. of Hercules, Calif.

27 Apr 2007

Better risk management could cut MRSA infection rates

The larger and busier, an NHS hospital is, the higher the MRSA infection rate, research from the Nottingham University Business School has revealed.

27 Apr 2007

Financial incentives help control MRSA infections in NHS hospitals

Improved levels of risk management standards in NHS hospitals would reduce MRSA infections by between 11% and 20%, according to new research by Professor Neil Rickman of the University of Surrey and colleagues.

25 Apr 2007

Cell Therapeutics settles law suit with Government

Cell Therapeutics has announced that it has settled all government claims arising out of a Department of Justice investigation into allegations regarding alleged overpayments by Medicare to doctors who prescribed the anti-cancer drug, TRISENOX.

18 Apr 2007

Coley Pharmaceutical licenses VaxImmune to Merck

Coley Pharmaceutical Group has announced that Merck & Co has licensed Coley's VaxImmune vaccine adjuvant for incorporation into vaccines being developed by Merck for certain infectious diseases and Alzheimer's disease.

15 Apr 2007

Barr Pharmaceuticals receives Notice of Allowance for Seasonale patent

Barr Pharmaceuticals has announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for the reissuance of U.S. Patent 5,895,032 ('032), relating to Barr's SEASONALE extended-cycle oral contraceptive.

10 Apr 2007

Palomar Medical resolves patent issue with Alma Lasers

Palomar Medical Technologies has announced the resolution of its on- going patent infringement and trade dress infringement lawsuit against Alma Lasers, Inc.

4 Apr 2007

Synergetics USA updates shareholders on Iridex patent case

Synergetics USA has announced the following update to its shareholders on the status of the pending Iridex patent infringement lawsuit.

12 Mar 2007

Allowing greater access to drug safety data would enable researchers to better evaluate risks

For years, pharmaceutical companies have sought to restrict public access to drug safety data collected in clinical trials on the basis that it is proprietary information, arguing that competitors could use that information in the development of their own products.

8 Mar 2007